top of page
Vision & Values
Vision & Values
History
.jpg)
2021
-
Completed lead compound screening for Osteoarthritis therapy
-
Conduct the GLP toxicity studies for AMD therapeutic drug
2020
-
Completed lead compound screening as KRAS inhibitor
-
Completed lead compound screening for AMD therapy
-
Completed lead compound screening for Anti-Cancer drug
-
Completed lead compound screening for therapeutic agent in Covid-19
-
Patents application for drug substance and method of use
2019
-
Patent application of novel active compounds
-
Completed active compound screening as BET inhibitors
2018
-
BenoBio Co., Ltd. Established (AUG. 2018)
-
Completed lead compound screening as epigenetic regulators
bottom of page